OncoThAI's research work is named in the "Health Trophies" category with the FLUXMEDICARE device manufactured and marketed by the company TEXINOV
The FLUXMEDICARE device, resulting from ONCO THAI's research work and manufactured and then marketed by the company TEXINOV, is particularly dedicated to the treatment of actinic keratosis by dynamic phototherapy. It is currently nominated in the "Health Trophies" category as part of the "Trophées d'Avenir", by Europe 1.
